Recce Pharmaceuticals Ltd.ASX: RCE

Phase I Clinical Trial R327 Advances to High Dose Cohort

Apr 12, 2022 at 4:29 AM UTC · Issued by Recce Pharmaceuticals Ltd.

Recce Ltd has released a press release.

View Attachment